TCM product approved for sale in Singapore
By Zhang Yu in Shijiazhuang |
chinadaily.com.cn |
Updated: 2020-05-07 15:56
Share
Share - WeChat
Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
- Flags spotlight Hebei's enduring war legacy
- Harbin Institute of Technology opens China-SCO doctoral training center
- Xi extends congratulations to plenary session of China-Russia friendship committee
- China unveils asteroid defense mission plan
- China's Galactic Energy launches three satellites
- Former securities regulator Yi Huiman under probe
